Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
- 19 May 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 2 (32), 32ra35
- https://doi.org/10.1126/scitranslmed.3001143
Abstract
Hepatitis B virus (HBV)–induced hepatitis and carcinogen-induced hepatocellular carcinoma (HCC) are associated with serum androgen concentration. However, how androgen or the androgen receptor (AR) contributes to HBV-induced hepatocarcinogenesis remains unclear. We found that hepatic AR promotes HBV-induced hepatocarcinogenesis in HBV transgenic mice that lack AR only in the liver hepatocytes (HBV-L-AR−/y). HBV-L-AR−/y mice that received a low dose of the carcinogen N′-N′-diethylnitrosamine (DEN) have a lower incidence of HCC and present with smaller tumor sizes, fewer foci formations, and less α-fetoprotein HCC marker than do their wild-type HBV-AR+/y littermates. We found that hepatic AR increases the HBV viral titer by enhancing HBV RNA transcription through direct binding to the androgen response element near the viral core promoter. This activity forms a positive feedback mechanism with cooperation with its downstream target gene HBx protein to promote hepatocarcinogenesis. Administration of a chemical compound that selectively degrades AR, ASC-J9, was able to suppress HCC tumor size in DEN-HBV-AR+/y mice. These results demonstrate that targeting the AR, rather than the androgen, could be developed as a new therapy to battle HBV-induced HCC.Keywords
This publication has 46 references indexed in Scilit:
- Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidyOncogene, 2010
- Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related DeathGastroenterology, 2010
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancerNature, 2010
- Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis BHepatology, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirHepatology, 2008
- Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular CarcinomaGastroenterology, 2008
- Targeting the stromal androgen receptor in primary prostate tumors at earlier stagesProceedings of the National Academy of Sciences, 2008
- Androgen receptor is a tumor suppressor and proliferator in prostate cancerProceedings of the National Academy of Sciences, 2008
- Impacts of chemicals on liver cancer riskSeminars in Cancer Biology, 2000